Notes: The Fourth ACCP Consensus Conference on Antithrombotic
Therapy recommends that an INR of 2.0 to 3.0 be used in patients
with atrial fibrillation.
The information in this
web site is not a substitute for medical advice or treatment.
Consultation with your doctor or health care professional is recommended.